Navigation Links
Sangamo BioSciences Reports Second Quarter 2009 Financial Results
Date:7/29/2009

nd License Agreement with Genentech, Inc., a wholly-owned member of the Roche Group. Genentech scientists demonstrated the successful knockout of two pre-selected genes in a Chinese hamster ovary (CHO) cell line using Sangamo's proprietary zinc finger DNA-binding protein nuclease (ZFN) technology. Genentech is using ZFN technology to generate cell lines with novel characteristics for pharmaceutical protein production purposes. The milestone achievement triggered a payment from Genentech to Sangamo.
  • Publication in Nature and Science magazines of data demonstrating the successful application of ZFN technology in plant agriculture and in the generation of novel transgenic animals. Data were published in April in the scientific journal Nature by licensing partner Dow AgroSciences and Sangamo demonstrating the successful application of ZFP technology for the efficient generation of maize plants with multiple, commercially important traits. The techniques described are broadly applicable across plant species and traits and establish a new method for rapid and precise crop development. A second publication in July in the journal Science described a method for the rapid and efficient production of transgenic rats in which specific genes are deleted or knocked out. The technology opens the door for the production of knockout animals in species other than mouse and broadens the possibilities for new animal models of human disease.
  • Sangamo awarded Grand Challenges Explorations Grant for Innovative Global Health Research from the Bill & Melinda Gates Foundation. The grant will support an innovative global health research project conducted by Sangamo scientists titled "Zinc Finger Nucleases for In Vivo Treatment of HIV Infection."
  • Promotion of Philip D. Gregory, D. Phil. to Chief Scientific Officer in addition to his role as Vice President, Research. <
    '/>"/>

    • SOURCE Sangamo BioSciences, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4 5 6 7

    Related biology technology :

    1. Sangamo BioSciences Announces Second Quarter 2009 Conference Call and Webcast
    2. Sangamo BioSciences Announces Presentation at the Needham Life Sciences Conference
    3. Sangamo BioSciences Receives $100,000 Grand Challenges Explorations Grant for Innovative Global Health Research
    4. Sangamo BioSciences Announces Publication in Nature of the Use of Zinc Finger Nucleases to Accelerate Precision Trait Stacking in Commercial Crop Species
    5. Sangamo BioSciences Announces First Quarter 2009 Conference Call and Webcast
    6. Sangamo BioSciences Reports Fourth Quarter and Full Year 2008 Financial Results
    7. Sangamo BioSciences Initiates Phase 1 Trial of CCR5-ZFP Therapeutic to Treat HIV/AIDS
    8. Sangamo BioSciences Announces Fourth Quarter and Year-End 2008 Conference Call and Webcast
    9. Sigma-Aldrich and Sangamo BioSciences Announce the Achievement of Key Throughput Milestone in Research Reagents Agreement
    10. Sangamo BioSciences to Present at the 27th Annual J.P. Morgan Healthcare Conference
    11. Sangamo BioSciences to Webcast Annual Investor and Analyst Briefing and Presentation at Piper Jaffray Health Care Conference

    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/24/2009)..., SANMATEO,Calif.,Nov.24/PRNewswire-FirstCall...lcompanyfocusedondevelopingandcommercializingnovel...iTonno,PresidentandChiefExecutiveOfficer,isschedul...nference,tobeheldDecember1-2,2009atTheNewYorkPalac...nGhiglieri,ChiefFinancialOfficer,willbeavailableto...
    (Date:11/24/2009)..., ,Primaryefficacyendpointhasbeenmetforpatient..., QUEBECCITY,Nov.24/PRNewswire-FirstCall/-AEt...y"),aglobalbiopharmaceuticalcompanyfocusedonendocr...cydatafromaPhase2studywithitstargetedcytotoxicpept...thadvancedorrecurrentendometrialcancer.Inapersonal...
    (Date:11/24/2009)..., REDWOODCITY,Calif.,Nov.24/PRNewswire-FirstC...cedthatRandyScott,GenomicHealth,sExecutiveChairman...onferenceinNewYorkCityonTuesday,December1,2009at10...hivedwebcastofthepresentation,visittheInvestorRela...stor.genomichealth.com .Pleaseconnecttothewebsitea...
    (Date:11/24/2009)..., SEATTLE,Nov.24/PRNewswire-FirstCall/--CellT...willpresentatthe21stAnnualPiperJaffrayHealthCareCo...ttheNewYorkPalaceHotel. ,, CTIwillpresentonTues...oor).AliveaudiowebcastofCTI,spresentationwillbeava...availableforreplayafterwards. , ,PiperJaffrayHeal...
    Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Genomic Health to Present at Piper Jaffray Health Care Conference 2
    ...omic (OTC,Bulletin Board: TBIO) today announced th..., will present at the Rodman & Renshaw 10th Annual...2008 at the New York,Palace Hotel in New York City...Officer, will be available to respond to questions...enshaw 10th Annual Healthcare Conference Date: ...
    ...ThromboGenics NV,(Euronext Brussels: THR), a biote...for eye disease, vascular disease and cancer, is t... period ended 30 September 2008., Patrik De Haes,...ncement, said: "ThromboGenics, clinical developmen... are now working hard to prepare for the,Phase III...
    ... Genomics to Present at Rodman & Renshaw,10th Annu...30 GMT, by,Rosetta Genomics Ltd nasdaq:ROSG over P...the company that new webcast information has been ...ed release follows:, , Rosetta Genomics Ltd. (Na...RNA-based diagnostics, announced today it,will pre...
    Other Biology Technology:Transgenomic to Present at Rodman & Renshaw 10th Annual Healthcare Conference 2ThromboGenics N.V.: Business Update 2ThromboGenics N.V.: Business Update 3ThromboGenics N.V.: Business Update 4ThromboGenics N.V.: Business Update 5ThromboGenics N.V.: Business Update 6ThromboGenics N.V.: Business Update 7ThromboGenics N.V.: Business Update 8/C O R R E C T I O N -- Rosetta Genomics Ltd/ 2/C O R R E C T I O N -- Rosetta Genomics Ltd/ 3/C O R R E C T I O N -- Rosetta Genomics Ltd/ 4/C O R R E C T I O N -- Rosetta Genomics Ltd/ 5/C O R R E C T I O N -- Rosetta Genomics Ltd/ 6
    (Date:11/25/2009)...y be just as vital to your health as what you eat,...gical Studies. Their experiments in mice revealed ...enes in the liverthe body,s metabolic clearinghous...e body,s circadian clock as conventional wisdom ha...y of a large number of genes completely independen...
    (Date:11/24/2009)... flabby arteries from collapsing have been true li...no longer needed -- once the arteries are strength... had no choice but to leave them in place. , Pro...tment of Biomedical Engineering has developed a ne... where they,re needed, then dissolves. , "Our ne...
    (Date:11/24/2009)...s a matter of debate. A high-profile study a few y... of their carbon from trees and leaves, evidence f...quatic ecosystems. , But new research from the U...o be true. Algae provide a much richer diet for fi...ublished this week in the Proceedings of the Nati...
    Breaking Biology News(10 mins):Feeding the clock 2Feeding the clock 3A coating for life 2Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3Researchers focus on helping dying patients take care of unfinished business 61554 1Researchers focus on helping dying patients take care of unfinished business 61554 2Researchers focus on helping dying patients take care of unfinished business 61554 3Members of Congress university leaders scientists launch ScienceWorksForUS 10775 1Members of Congress university leaders scientists launch ScienceWorksForUS 10775 2Members of Congress university leaders scientists launch ScienceWorksForUS 10775 3Members of Congress university leaders scientists launch ScienceWorksForUS 10775 4Aspen Dermatology Builds Client Communication with Training by Web Campus World Wide 61551 1Aspen Dermatology Builds Client Communication with Training by Web Campus World Wide 61551 2Aspen Dermatology Builds Client Communication with Training by Web Campus World Wide 61551 3Aspen Dermatology Builds Client Communication with Training by Web Campus World Wide 61551 4
    ... This release is available in French and Span...om more than 160 endorsed science projects assembl...nched in March 2007, the IPY covers a two-year per... the alternate seasons in both polar regions. A jo...ts to better monitor and understand the Arctic and...
    ... 47% Growth in Fourth Quarter Revenues , , WALL, ...lletin Board: BKYI), a leader in wireless public s...lutions, today reported results for the fourth qua...y,s results reflected profitability for the fourth...well as strong revenue growth for the quarter and ...
    ... Stem cells scientists at UCLA showed for the fir...cells can be differentiated into electrically acti...ying and treating neurological disorders. , Addi...ells appeared to be similar in function and effici...lls, although further testing needs to be done to ...
    Other Biology News:Polar research reveals new evidence of global environmental change 2Polar research reveals new evidence of global environmental change 3BIO-key(R) Reports Profitability for Fourth Quarter and Full Year 2008 2BIO-key(R) Reports Profitability for Fourth Quarter and Full Year 2008 3BIO-key(R) Reports Profitability for Fourth Quarter and Full Year 2008 4BIO-key(R) Reports Profitability for Fourth Quarter and Full Year 2008 5BIO-key(R) Reports Profitability for Fourth Quarter and Full Year 2008 6UCLA stem cells scientists make electrically active motor neurons from iPS cells 2
    Electroporation Cuvettes, 4 mm gap. 50 from Thermo Scientific
    ...rm of Tobacco Etch Virus (TEV) protease that is hi...ly more stable than native TEV protease, resulting...y recognizes a seven amino acid (Glu-Asn-Leu-Tyr-P...it useful for removing affinity tags from fusion p...
    ...ble quadrupole MS detector optimized for HPLC uses... and 2-D LC, as well as capillary and prep scale s... create a finer spray mist for high sensitivity, e...ile providing for high reliability, lower source c...
    Rabbit Anti-S-100A10 (H-80) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
    Biology Products: